Utama › Kanser Kolorektal › North Carolina

Kajian klinikal Kanser Kolorektal di North Carolina

44 kajian untuk Kanser Kolorektal sedang mencari peserta di lokasi di North Carolina.

Bandar di North Carolina

Teks kajian rasmi (Bahasa Inggeris)

The Vanguard Study: Testing a New Way to Screen for Cancer

UNC Lineberger Comprehensive Cancer Center, Chapel Hill
Durham VA Medical Center, Durham

Mengambil pesertaSukarelawan sihat dialu-alukan

Umur 45 hingga 75 · Semua jantina · Dikemas kini 5 Okt 2026 · NCT06995898

A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer

Duke University Medical Center /ID# 279322, Durham

Mengambil pesertaFasa 3

Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07525206

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Carolina Cancer Research Center, Wilson

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06270706

Colonoscopy vs Stool Testing for Older Adults With Colon Polyps

Wake Forest University Health Sciences, Charlotte

Mengambil peserta

Umur 65 hingga 82 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05612347

Family Communications After Genetic Testing

Southeastern Medical Oncology Center-Clinton, Clinton
CaroMont Regional Medical Center, Gastonia
Southeastern Medical Oncology Center-Goldsboro, Goldsboro
dan 2 lagi

Mengambil pesertaSukarelawan sihat dialu-alukan

Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07143487

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Duke University, Durham

Mengambil pesertaFasa 1/2

Umur 12 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT04585750

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

Carolinas Medical Center/Levine Cancer Institute, Charlotte
Atrium Health Cabarrus/LCI-Concord, Concord
East Carolina University, Greenville
dan 1 lagi

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05673148

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

AdventHealth Infusion Center Asheville, Asheville
Southeastern Medical Oncology Center-Clinton, Clinton
AdventHealth Infusion Center Haywood, Clyde
dan 6 lagi

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan

Umur 40 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05334069

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Exelixis Clinical Site #12, Durham

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT05176483

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Duke Cancer Center Cary, Cary
Duke Cancer Center - Investigational Chemotherapy Service, Durham
Duke Cancer Center, Durham
dan 2 lagi

Mengambil pesertaFasa 3

Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07222800

Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)

Duke Cancer Center, Durham

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT05482893

A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer

University of North Carolina Medical Center /ID# 267786, Chapel Hill

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT06820463

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

University of North Carolina at Chapel Hill, Chapel Hill

Mengambil pesertaFasa 3

Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06662786

Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

Duke University Medical Center, Durham
Duke Cancer Center Raleigh, Raleigh
Wake Forest University Health Sciences, Winston-Salem

Mengambil pesertaFasa 3

Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT05863195

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Local Institution - 0290, Charlotte

Mengambil pesertaFasa 2/3

Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT07221357

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

Duke University Medical Center, Durham

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07213791

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

Duke University Medical Center, Durham

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06445062

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Duke University School of Medicine, Durham

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Semua jantina · Dikemas kini 16 Sep 2026 · NCT05786924

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

Messino Cancer Center, Asheville
The University of North Carolina At Chapel Hill, Chapel Hill
Oncology Specialists of Charlotte, Charlotte

Mengambil pesertaFasa 3

Umur 18 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT07284849

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

Clinical Study Site, Pinehurst

Mengambil pesertaFasa 3

Umur 18 ke atas · Semua jantina · Dikemas kini 8 Sep 2026 · NCT07228832

Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation

Duke Cancer Center, Durham

Mengambil pesertaFasa 3

Umur 18 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT06252649

MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors

Duke University Medical Center, Durham

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 24 Ogo 2026 · NCT06586515

A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer.

Duke University Medical Center - Duke Cancer Center, Durham

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT07235293

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Duke University, Durham

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT05919264

A Study of DM002 in Patients With Advanced Solid Tumors

Carolina BioOncology Institute, LLC, Huntersville

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Semua jantina · Dikemas kini 7 Ogo 2026 · NCT06751329

A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors

Clinical Trial Site, Huntersville

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Semua jantina · Dikemas kini 6 Ogo 2026 · NCT07749586

A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)

GSK Investigational Site, Durham

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Semua jantina · Dikemas kini 3 Ogo 2026 · NCT06885034

AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors

Duke Cancer Center, Durham

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 30 Jul 2026 · NCT07094113

Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

Investigative Site #131, Raleigh

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 23 Jul 2026 · NCT06974110

A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer

Duke University Hospital, Durham
Duke University Medical Center, Duke Cancer Center, Durham
Duke University Medical Center, Durham
dan 2 lagi

Mengambil pesertaFasa 3

Umur 18 ke atas · Semua jantina · Dikemas kini 22 Jul 2026 · NCT05253651

Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy

Duke University Medical Center, Durham

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 15 Jul 2026 · NCT06937177

PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival

Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill

Mengambil peserta

Umur 18 ke atas · Semua jantina · Dikemas kini 14 Jul 2026 · NCT06896162

A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

Duke University Medical Center /ID# 279457, Durham

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 10 Jul 2026 · NCT07023289

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

Research Site, Durham

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 10 Jun 2026 · NCT06835569

Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

Duke University Medical Center, Durham

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Semua jantina · Dikemas kini 8 Jun 2026 · NCT03947385

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

Duke Cancer Center, Durham
Carolina BioOncology Institute, Huntersville

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 3 Jun 2026 · NCT06040541

Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors

Cone Health MedCenter Asheboro, Asheboro
Cone Health Cancer Center at Alamance Regional, Burlington
Cone Health Cancer Center, Greensboro
dan 3 lagi

Mengambil pesertaFasa 3Sukarelawan sihat dialu-alukan

Umur 18 ke atas · Semua jantina · Dikemas kini 31 Mac 2026 · NCT07018869

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Atrium Health Stanly/LCI-Albemarle, Albemarle
Cone Health MedCenter Asheboro, Asheboro
Cone Health Cancer Center at Alamance Regional, Burlington
dan 21 lagi

Mengambil pesertaKajian pemerhatian

Umur 18 ke atas · Semua jantina · Dikemas kini 17 Mac 2026 · NCT06418204

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

Carolina BioOncology Institute, Huntersville

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Semua jantina · Dikemas kini 18 Feb 2026 · NCT07030257

Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors

Duke Cancer Institute, Durham

Mengambil peserta

Umur 18 hingga 39 · Semua jantina · Dikemas kini 28 Jan 2026 · NCT06371768

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.